CORRECTION
Published on 17 Jul 2025
Correction: Bispecific antibody for lung cancer: mechanisms and clinical insights
doi 10.3389/fimmu.2025.1656082
- 166 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Bispecific Antibodies and their Conjugates in Solid Tumors and Hematological Malignancies
Bispecific Antibodies and their Conjugates in Solid Tumors and Hematological Malignancies
2,389
Total downloads
12k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Accepted on 04 Jul 2025
Blinatumomab in Pediatric B-acute Lymphoblastic Leukemia
doi 10.3389/fimmu.2025.1611701
- 246 views
ORIGINAL RESEARCH
Published on 18 Jun 2025
Characterization and functional evaluation of JS207, a novel bispecific antibody against human PD-1 and VEGFA
doi 10.3389/fimmu.2025.1612547
- 2,108 views
REVIEW
Published on 29 May 2025
Bispecific antibody for lung cancer: mechanisms and clinical insights
doi 10.3389/fimmu.2025.1572802
- 1,451 views
SYSTEMATIC REVIEW
Published on 25 Apr 2025
Effectiveness and safety of teclistamab for relapsed or refractory multiple myeloma: a systematic review and meta-analysis
doi 10.3389/fimmu.2025.1565407
- 2,682 views
MINI REVIEW
Published on 09 Apr 2025
Bispecific antibodies in immunotherapy for acute leukemia: latest updates from the 66th annual meeting of the American society of hematology, 2024
doi 10.3389/fonc.2025.1566202
- 1,662 views
CASE REPORT
Published on 31 Mar 2025
Successful treatment of primary refractory DLBCL/HGBL - MYC/BCL2 transformed from FL using glofitamab: a case report
doi 10.3389/fimmu.2025.1566035
- 1,677 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: